NDC 71858-0017 Tirosint
Levothyroxine Sodium Capsule Oral
NDC Code 71858-0017-1
Package Description: 1 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
NDC Code 71858-0017-4
Package Description: 3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
What is NDC 71858-0017?
The NDC code 71858-0017 is assigned by the FDA to the product Tirosint which is a human prescription drug product labeled by Ibsa Pharma Inc.. The generic name of Tirosint is levothyroxine sodium. The product's dosage form is capsule and is administered via oral form. The product is distributed in 2 packages with assigned NDC codes 71858-0017-1 1 blister pack in 1 carton / 10 capsule in 1 blister pack, 71858-0017-4 3 blister pack in 1 carton / 10 capsule in 1 blister pack. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
What are the uses for Tirosint?
Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as certain types of goiters, thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.
What are Tirosint Active Ingredients?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- LEVOTHYROXINE SODIUM 62.5 ug/1 - The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
What is the NDC to RxNorm Crosswalk for Tirosint?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 1923047 - levothyroxine sodium 175 MCG Oral Capsule
- RxCUI: 1923047 - levothyroxine sodium 0.175 MG Oral Capsule
- RxCUI: 1923049 - Tirosint 175 MCG Oral Capsule
- RxCUI: 1923049 - levothyroxine sodium 0.175 MG Oral Capsule [Tirosint]
- RxCUI: 1923049 - Tirosint 0.175 MG Oral Capsule
Which are the Pharmacologic Classes for Tirosint?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the disclaimer below.
We have moved the product label and warning information to a dedicated page, please follow the link below:View Product Label